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Dear Editor,
 In December 2019, numerous severe pneumonia without 
any specific etiology found in Wuhan, China, and after a 
while, widespread to all seven continents and became a 
global concern. Coronaviruses are a shared type of virus 
among humans, and animals, that cause multiple injuries 
and infections in both; some can adapt and survive, 
but not all of them. This letter aimed to highlight the 
neurological manifestations of cases with COVID-19 
infection. Based on the recently published studies, men 
admitted to hospitals more than women,1 individuals with 
underlying pathology, including cardiovascular disease, 
diabetes, and respiratory manifestations, are at higher risk. 
Investigations have already confirmed the neurological 
involvement in SARS-CoV and MERS-CoV infections.2 
COVID-19 infection can cause various demonstrations, 
such as fever, myalgia, diarrhea, and cough.3 Although 
COVID-19 mainly causes the severe respiratory syndrome, 
which is one of the most important causes of death, the 
latest studies demonstrate, in extreme cases, neurological 
manifestation is critical. An investigation conducted by 
Bo Hu et al. in China demonstrate the higher incidence 
of neurological symptom and sign in severe cases of 
COVID-19 infection.4 Neurological manifestation of 
COVID-19 infection classified into two categorizes 
central nervous system (CNS) symptoms and peripheral 
nervous system (PNS) symptoms. CNS symptoms 
included dizziness, headache, impaired consciousness, 
acute cerebrovascular disease, ataxia, and epilepsy. 
However, PNS symptoms are less severe and introduced as 
hyposmia, hypoplasia, neuralgia, and hypogeusia. In term 
of laboratory findings, based on the clinical symptoms 
and sign, patients classified into severe and non-severe 
categorizes; in patients with PNS involvement, laboratory 
findings are not helpful, however, in patients with CNS 
engagement, severe cases demonstrate lower lymphocyte 
and platelet counts besides of higher blood urea nitrogen 
levels contrasted individuals without CNS involvement or 
with non-severe CNS involvement.3
Even though COVID-19 respiratory infections and 
cardiovascular events are the leading cause of mortality, 
clinical awareness of physicians about neurological 
accidents, reduce the mortality rate in infected individuals. 
Future investigations on the determination of the specific 
risk factors or protective determinants concerning 
neurological events are needed to diminish the risk of 
these complications in COVID-19 infection.
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